Apnar Pharma launches generic Bystolic

Apnar Pharma has launched nebivolol hydrochloride tablets. The launch includes all four strengths of nebivolol (2.5 mg, 5 mg, 10 mg and 20mg) in all presentations. The product is the generic of Allergan’s Bystolicn.

It is indicated as an antihypertensive.

[Read more: Challenges continue, but generics companies see a bright future with] biosimilars

Greg Stofko, executive vice president of sales and marketing, said, “We are excited to be launching Nebivolol which is the first in a series of launches by Apnar in 2024. We are pleased to be able to offer the whole family of this important medication to our valued customers and patients as it also expands our portfolio and footprint in the U.S. marketplace.”